Genusetics Inc- Changing the face of Alzheimer’s and health care. Genusetics is developing an affordable, convenient prognostic test that does more than just identify the Alzheimer’s genes. It evaluates risk of developing the disease and its progression, before damage is done, while mitigation is still possible and it can be delivered Direct To Consumer. With additional research, this methodology and delivery system can potentially be applied to other illness like diabetes and heart disease.